The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
In the complex relationship between human well-being and economic vitality, population health remains a crucial foundation ...
Target RWE, a leader in advancing modern evidence generation for complex clinical and regulatory challenges, today announced the return of M. Alan Brookhart, Ph.D., to the organization as President of ...